Spyre Therapeutics, Inc. (SYRE) Insider Trading -- Recent Executive & Director Transactions

10 insiders reported 103 Form 4 transactions for Spyre Therapeutics, Inc. (SYRE) over the past 18 months (most recent 2026-09-03). Recent activity: King-Jones Heidy (See Remarks) Sell 6,206 shares, King-Jones Heidy (See Remarks) Sell 400 shares, Burrows Scott L (Chief Financial Officer) Buy 7,500 shares, Turtle Cameron (Chief Executive Officer) Sell 8,400 shares, King-Jones Heidy (See Remarks) Sell 4,845 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-09-03King-Jones HeidySee RemarksSell6,206$547,183
2026-09-03King-Jones HeidySee RemarksSell400$36,000
2026-09-03Burrows Scott LChief Financial OfficerBuy7,500$108,750
2026-09-03Turtle CameronChief Executive OfficerSell8,400$732,060
2026-09-03King-Jones HeidySee RemarksSell4,845$418,608
2026-09-03Burrows Scott LChief Financial OfficerSell900$77,625
2026-09-03Turtle CameronChief Executive OfficerSell3,700$325,822
2026-09-03King-Jones HeidySee RemarksBuy27,999$405,986
2026-09-03Burrows Scott LChief Financial OfficerSell4,384$381,890
2026-09-03Turtle CameronChief Executive OfficerSell400$35,628
2026-09-03Turtle CameronChief Executive OfficerSell2,500$215,900
2026-09-03Burrows Scott LChief Financial OfficerSell2,016$177,468
2026-09-03King-Jones HeidySee RemarksSell400$35,752
2026-09-03Burrows Scott LChief Financial OfficerSell200$17,808
2026-09-03King-Jones HeidySee RemarksBuy400$5,800
2026-09-03Burrows Scott LChief Financial OfficerSell18,232$1.6M
2026-09-03King-Jones HeidySee RemarksSell16,548$1.4M
2026-08-10Albers Jeffrey W.DirectorBuy5,000$51,950
2026-08-10Albers Jeffrey W.DirectorSell5,000$522,350
2026-08-10Albers Jeffrey W.DirectorSell10,000$1.0M
2026-08-10Albers Jeffrey W.DirectorSell8,000$835,040
2026-08-05Burrows Scott LChief Financial OfficerSell5,100$485,571
2026-08-05Turtle CameronChief Executive OfficerSell800$75,176
2026-08-05Burrows Scott LChief Financial OfficerBuy7,500$108,750
2026-08-05Turtle CameronChief Executive OfficerSell7,157$680,631

Source: SEC Form 4 filings · as of 2026-09-03